TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
IMUX

Immunic Inc

Healthcare · Biotechnology

10.60$ +2.6% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement IMUX
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0%
3.4%
96.6%
500,766.7%
187,000.0%
687,766.7%
-687,766.7%
0.0%
-682,816.7%
-30,133.3%
-682,816.7%
-657,633.3%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?